Medical Weight Loss for Milwaukee, Wisconsin Residents
Milwaukee, Wisconsin residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Milwaukee through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Milwaukee Residents Choose New Hope Weight Loss
Milwaukee patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Wisconsin and beyond since 2020.
Milwaukee is served through telehealth from our Costa Mesa, California clinic. The consultation, prescription, and follow-up all happen by secure video.
Although our clinic is physically in Costa Mesa, California, Milwaukee residents receive the same physician-supervised care without leaving Wisconsin. We care for patients throughout Downtown, the Third Ward, Bay View, the East Side, and the greater Milwaukee area. There is no distance surcharge for Milwaukee patients, and HSA, FSA, Klarna, and Affirm are all accepted.
For Milwaukee residents, being seen by video means starting this week instead of waiting for an in-person appointment. Pricing for Milwaukee is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Milwaukee
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Milwaukee
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Milwaukee address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Milwaukee
How do I get treatment from Milwaukee?
As a Milwaukee, Wisconsin patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Milwaukee?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Milwaukee in cold-pack packaging, no lines and no drive.
How much does it cost for Milwaukee patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Milwaukee do you serve?
We serve patients from across Milwaukee by telehealth, including Downtown, the Third Ward, Bay View, the East Side, and the greater Milwaukee area.
Can Milwaukee patients get treatment without traveling?
Yes. Milwaukee patients complete the entire program, intake, physician consultation with Dr. Sharma, dose titration, and follow-up, by telehealth, with compounded medication shipped to their Milwaukee address.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Milwaukee, Wisconsin by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.